Acamprosate has a chemical structure similar to that of amino acid neuromediators, such as taurine or gamma-amino-butyric acid (GABA), including an acetylation to permit passage across the blood brain barrier. It is indicated as therapy to maintain abstinence in alcohol-dependent patients.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Acamprosate is the active ingredient of these drugs:
Australia Austria Canada Ireland Netherlands
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):